vPush
Disposable variable-dose pen injector
A flexible, cartridge-based pen for chronic therapies that require variable dosing and repeat injections.
vPush
Disposable variable-dose pen injector
A flexible, cartridge-based pen for chronic therapies that require variable dosing and repeat injections.
vPush
Disposable variable-dose pen injector
A flexible, cartridge-based pen for chronic therapies that require variable dosing and repeat injections.
vPush
Disposable variable-dose pen injector
A flexible, cartridge-based pen for chronic therapies that require variable dosing and repeat injections.
Controlled manual injection with a smooth force profile
Controlled manual injection with a smooth force profile
Cartridge-based
system
Cartridge-based
system
Multi-dose capability for chronic therapy
Multi-dose capability for chronic therapy
Clear dose window and tactile feedback
Clear dose window and tactile feedback
For chronic therapies with frequent, flexible dosing
For chronic therapies with frequent, flexible dosing
Indications
Indications
Diabetes
Diabetes
GLP-1 / weight management
GLP-1 / weight management
Growth disorders (HGH)
Growth disorders (HGH)
Fertility treatments
Fertility treatments
Autoimmune therapies
Autoimmune therapies
Technical specifications
Technical specifications
Max dose
Max dose
0.80 ml
0.80 ml
Dose increment
Dose increment
0.01 ml
0.01 ml
Primary container
Primary container
Standard 3 ml cartridge according to ISO 11608-3
Standard 3 ml cartridge according to ISO 11608-3
Plunger
Plunger
8.5 mm or 11.5 mm
8.5 mm or 11.5 mm
Needles
Needles
Compatible with standard needles according to ISO 11608-2
Compatible with standard needles according to ISO 11608-2
Pre-validated packeges in development
Pre-validated packeges in development
vPush is being developed with regulatory-ready, pre-validated packages compatible with selected molecules. Biosimilars and close analogues can often follow the same route. For molecules or use cases outside the pre-validated paths, the platform is tuned to your molecule.
vPush is being developed with regulatory-ready, pre-validated packages compatible with selected molecules. Biosimilars and close analogues can often follow the same route. For molecules or use cases outside the pre-validated paths, the platform is tuned to your molecule.
Pre-validated packages
Pre-validated packages
Regulatory-ready device platforms in development for selected molecules including testing, documentation to give your team a shorter path to adopt.
Insulin
Liraglutide (GLP-1)
Semaglutide (GLP-1)
Somatotropin (HGH)
Teriparatide
Follitropin alfa (FSH)
Expected availability: end of 2026 / start of 2027
Expected availability: end of 2026 / start of 2027
Custom adpatations
Custom adpatations
For molecules or use cases outside the pre-validated paths, the platform is tuned to your molecule.
Contact us
©dVise Medtech Private Limited 2026
©dVise Medtech Private Limited 2026